stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Operating cash flow
AtriCure, Inc.'s operating cash flow for fiscal 2025 was $57.3M, up 369.8% from $12.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $68.5M. Over the past ten years it has ranged from −$22.1M (fiscal 2022) to $57.3M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. AtriCure, Inc. ranks 24th of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $57.3M | 369.80% |
| FY2024 | $12.2M | 172.17% |
| FY2023 | $4.5M | — |
| FY2022 | −$22.1M | — |
| FY2021 | −$13.8M | — |
| FY2020 | −$19.9M | — |
| FY2019 | −$15.8M | — |
| FY2018 | −$4.2M | — |
| FY2017 | −$8.9M | — |
| FY2016 | −$15.1M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $22.2M | — |
| Mar 2026 | −$4.0M | — |
| Dec 2025 | $20.0M | (25.04%) |
| Sep 2025 | $26.7M | 23.59% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| NVST Envista Holdings Corporation compare | $301.8M |
| STVN Stevanato Group S.p.A. compare | $289.2M |
| ICUI ICU Medical, Inc. compare | $279.2M |
| MMSI Merit Medical Systems, Inc. compare | $273.7M |
| XRAY DENTSPLY SIRONA Inc. compare | $272.0M |
| WRBY Warby Parker Inc. compare | $102.1M |
| ATRC AtriCure, Inc. | $68.5M |
| PLSE Pulse Biosciences, Inc compare | −$63.3M |
| MMED MiniMed Group, Inc. compare | −$134.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement